NYSE:ALBChemicals
Albemarle Idles Kemerton Capacity As Lithium Strategy And Valuation Evolve
Albemarle (NYSE:ALB) is idling the last active production train at its Kemerton lithium hydroxide facility in Western Australia, adjusting operations to current lithium market conditions.
The company reported Q4 2025 results that included asset write downs and a net loss, alongside efforts to tighten costs and optimize its asset base.
Albemarle is shifting more volume toward higher margin conversion channels and expanding its U.S. lithium supply presence, while also pursuing new growth...